Ethyl (2-amino-1,3-thiazol-4-yl)acetate
Names
[ CAS No. ]:
53266-94-7
[ Name ]:
Ethyl (2-amino-1,3-thiazol-4-yl)acetate
[Synonym ]:
Ethyl 2-(2-aminothiazol-4-yl)acetate
MFCD00005330
Ethyl (2-amino-1,3-thiazol-4-yl)acetate
(2-Amino-4-thiazolyl)acetic Acid Ethyl Ester
Ethyl-2-(2-amino-4-thiazole-4-yl) acetate
EINECS 258-452-1
4-Thiazoleacetic acid, 2-amino-, ethyl ester
Ethyl (2-AMino-4-thiazolyl)acetate
Ethyl 2-Amino-4-Thiazoleacetate
ethyl 2-(2-amino-1,3-thiazol-4-yl)acetate
Ethyl 2-aminothiazole-4-acetate
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
318.5±17.0 °C at 760 mmHg
[ Melting Point ]:
92-94 °C(lit.)
[ Molecular Formula ]:
C7H10N2O2S
[ Molecular Weight ]:
186.232
[ Flash Point ]:
146.4±20.9 °C
[ Exact Mass ]:
186.046295
[ PSA ]:
93.45000
[ LogP ]:
0.66
[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.576
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi:Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S37/39-S26
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2934100090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2934100090
[ Summary ]:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%
Articles
Acta Crystallogr. Sect. E Struct. Rep. Online 68(6) , m788-m789, (2012)
The asymmetric unit of the title compound, [CdCl(2)(C(7)H(10)N(2)O(2)S)(2)], contains two complex molecules with similar configurations. The Cd(II) atoms are each six-coordinated by two thiazole N and...
Bis(2-amino-thia-zole-4-acetato)aquazinc(II).Acta Crystallogr. Sect. E Struct. Rep. Online 65(12) , m1517-m1517, (2009)
In the title compound, [Zn(C(5)H(5)N(2)O(2)S)(2)(H(2)O)], the central Zn atom (2 site symmetry) is five-coordinated by two N and three O atoms [Zn-N = 2.047 (3) Å, Zn-O = 2.099 (2) and 1.974 (4) Å] in...
Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitusBioorg. Med. Chem. 22(7) , 2280-93, (2014)
Novel heteroaryl-containing benzamide derivatives were synthesized and screened using an in vitro assay measuring increases in glucose uptake and glucokinase activity stimulated by 10mM glucose in rat...